{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:29:27Z","timestamp":1773102567874,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":1143,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s13311-020-00912-8","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T10:12:09Z","timestamp":1597659129000},"page":"1031-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats"],"prefix":"10.1016","volume":"17","author":[{"given":"Nora","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-0686","authenticated-orcid":false,"given":"Samar","family":"Rezq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00912-8_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1007\/s13311-020-00912-8_bib2","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1007\/s13311-020-00912-8_bib3","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"issue":"5 Suppl","key":"10.1007\/s13311-020-00912-8_bib4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0885-3924(03)00065-4","article-title":"Unmet needs in the management of neuropathic pain","volume":"25","author":"Harden","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.36076\/ppj.2017.292","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers modulate the function of myelinated fibers after chemotherapy: a quantitative sensory testing study","volume":"20","author":"Roldan","year":"2017","journal-title":"Pain Physician"},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.peptides.2011.05.012","article-title":"New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine\/intracellular angiotensin II","volume":"32","author":"Zhuo","year":"2011","journal-title":"Peptides"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14737175.2016.1150179","article-title":"The therapeutic potential of renin angiotensin aldosterone system (RAAS) in chronic pain: from preclinical studies to clinical trials","volume":"16","author":"Bessaguet","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1007\/s13311-020-00912-8_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1248\/yakushi.129.593","article-title":"Ameliorative potential of spironolactone in diabetes induced hyperalgesia in mice","volume":"129","author":"Khan","year":"2009","journal-title":"Yakugaku Zasshi"},{"issue":"1-3","key":"10.1007\/s13311-020-00912-8_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2011.06.017","article-title":"Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats","volume":"667","author":"Jaggi","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1470320313503694","article-title":"Renin-angiotensin system in pain: existing in a double life?","volume":"15","author":"Bali","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"8","key":"10.1007\/s13311-020-00912-8_bib11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/HJH.0b013e32833a551a","article-title":"Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice","volume":"28","author":"Iwanami","year":"2010","journal-title":"J Hypertens"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib12","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.21040","article-title":"Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice","volume":"52","author":"Sagawa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1007\/s13311-020-00912-8_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol Pain"},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib14","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","article-title":"Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons","volume":"23","author":"Schafers","year":"2003","journal-title":"J Neurosci"},{"issue":"1-3","key":"10.1007\/s13311-020-00912-8_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.regpep.2009.09.001","article-title":"Angiotensin II activates JAK2\/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes","volume":"159","author":"Kandalam","year":"2010","journal-title":"Regul Pept"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-4159.2008.05566.x","article-title":"JAK\/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat","volume":"107","author":"Dominguez","year":"2008","journal-title":"J Neurochem"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2008.02.072","article-title":"Does COX2-dependent PGE2 play a role in neuropathic pain?","volume":"437","author":"Ma","year":"2008","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1007\/s13311-020-00912-8_bib18","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1523-1755.2005.00670.x","article-title":"Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species","volume":"68","author":"Jaimes","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib19","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver","volume":"285","author":"Bataller","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2006.10.013","article-title":"Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice","volume":"194","author":"Recinos","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cvr\/cvp073","article-title":"Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension","volume":"82","author":"Kang","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib22","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1167\/iovs.09-3375","article-title":"Role of IL-6 in angiotensin II-induced retinal vascular inflammation","volume":"51","author":"Rojas","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1-3","key":"10.1007\/s13311-020-00912-8_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.regpep.2007.07.001","article-title":"Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation","volume":"144","author":"Clark","year":"2007","journal-title":"Regul Pept"},{"issue":"Pt 4","key":"10.1007\/s13311-020-00912-8_bib24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awr025","article-title":"JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats","volume":"134","author":"Tsuda","year":"2011","journal-title":"Brain"},{"key":"10.1007\/s13311-020-00912-8_bib25","doi-asserted-by":"crossref","unstructured":"Austin PJ, A Wu, and G Moalem-Taylor, Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp, 2012(61).","DOI":"10.3791\/3393-v"},{"issue":"2-3","key":"10.1007\/s13311-020-00912-8_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"1-2","key":"10.1007\/s13311-020-00912-8_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2009.02.001","article-title":"Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats","volume":"59","author":"Jain","year":"2009","journal-title":"Pharmacol Res"},{"issue":"5464","key":"10.1007\/s13311-020-00912-8_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"issue":"1-2","key":"10.1007\/s13311-020-00912-8_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(02)00039-8","article-title":"Pharmacological characterisation of the spared nerve injury model of neuropathic pain","volume":"98","author":"Erichsen","year":"2002","journal-title":"Pain"},{"issue":"1-3","key":"10.1007\/s13311-020-00912-8_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2008.10.004","article-title":"Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine","volume":"600","author":"Thibault","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pain.2007.11.017","article-title":"Vagal damage enhances polyneuropathy pain: additive effect of two algogenic mechanisms","volume":"138","author":"Weissman-Fogel","year":"2008","journal-title":"Pain"},{"key":"10.1007\/s13311-020-00912-8_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease","volume":"1352","author":"Yamada","year":"2010","journal-title":"Brain Res"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13311-018-0613-8","article-title":"Brain renin-angiotensin system blockade attenuates methamphetamine-induced hyperlocomotion and neurotoxicity","volume":"15","author":"Jiang","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"Suppl 4","key":"10.1007\/s13311-020-00912-8_bib36","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/00005344-198900000-00008","article-title":"Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288","volume":"14","author":"Gohlke","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1007\/s13311-020-00912-8_bib38","first-page":"755","article-title":"Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats","volume":"46","author":"van Meel","year":"1996","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00912-8_bib39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/57.suppl_1.S3","article-title":"Overview of the angiotensin-converting-enzyme inhibitors","volume":"57","author":"Piepho","year":"2000","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"10.1007\/s13311-020-00912-8_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/bdd.1950","article-title":"Absorption and cleavage of enalapril, a carboxyl ester prodrug, in the rat intestine: in vitro, in situ intestinal perfusion and portal vein cannulation models","volume":"36","author":"Holenarsipur","year":"2015","journal-title":"Biopharm Drug Dispos"},{"issue":"11","key":"10.1007\/s13311-020-00912-8_bib42","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1007\/s12035-019-1616-0","article-title":"Losartan, an angiotensin II type 1 receptor antagonist, alleviates mechanical hyperalgesia in a rat model of chemotherapy-induced neuropathic pain by inhibiting inflammatory cytokines in the dorsal root ganglia","volume":"56","author":"Kim","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10641969809053215","article-title":"Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain","volume":"20","author":"Wagner","year":"1998","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1470320314556171","article-title":"Ameliorative potential of angiotensin-converting enzyme inhibitor (ramipril) on chronic constriction injury of sciatic nerve induced neuropathic pain in mice","volume":"16","author":"Kaur","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.17712\/nsj.2015.2.20140511","article-title":"Telmisartan inhibits hyperalgesia and inflammatory progression in a diabetic neuropathic pain model of Wistar rats","volume":"20","author":"Al-Rejaie","year":"2015","journal-title":"Neurosciences"},{"issue":"12","key":"10.1007\/s13311-020-00912-8_bib46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jfma.2013.05.013","article-title":"Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats","volume":"113","author":"Kukkar","year":"2014","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1523\/JNEUROSCI.1647-17.2017","article-title":"Brainstem pain-control circuitry connectivity in chronic neuropathic pain","volume":"38","author":"Mills","year":"2018","journal-title":"J Neurosci"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bjan.2016.02.012","article-title":"Evaluation of sciatic nerve damage following intraneural injection of bupivacaine, levobupivacaine and lidocaine in rats","volume":"66","author":"Sen","year":"2016","journal-title":"Braz J Anesthesiol"},{"issue":"5","key":"10.1007\/s13311-020-00912-8_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/187152711796235041","article-title":"Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain","volume":"10","author":"Jaggi","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2004.10.016","article-title":"Comparison of five different rat models of peripheral nerve injury","volume":"80","author":"Dowdall","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"1-3","key":"10.1007\/s13311-020-00912-8_bib51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.08.050","article-title":"Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats","volume":"648","author":"Jaggi","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pain.2007.10.011","article-title":"Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat","volume":"137","author":"Jiang","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib53","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"issue":"12","key":"10.1007\/s13311-020-00912-8_bib54","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","article-title":"Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin\u2013angiotensin system","volume":"22","author":"Kurtz","year":"2004","journal-title":"J Hypertens"},{"issue":"8","key":"10.1007\/s13311-020-00912-8_bib55","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.nucmedbio.2012.06.012","article-title":"Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques","volume":"39","author":"Noda","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib56","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.nucmedbio.2012.01.008","article-title":"Whole-body distribution and radiation dosimetry of [11C] telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3","volume":"39","author":"Shimizu","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(98)00982-3","article-title":"Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain","volume":"260","author":"Levy","year":"1999","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib58","doi-asserted-by":"crossref","first-page":"13508","DOI":"10.1038\/s41598-019-49850-2","article-title":"Magnetic resonance imaging as a biomarker in rodent peripheral nerve injury models reveals an age-related impairment of nerve regeneration","volume":"9","author":"Giorgetti","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14740338.4.3.433","article-title":"Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity","volume":"4","author":"O'Callaghan","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib60","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm0796-814","article-title":"Bradykinin\u2013evoked sensitization of airway sensory nerves: a mechanism for ACE\u2013inhibitor cough","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"issue":"5944","key":"10.1007\/s13311-020-00912-8_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/306686a0","article-title":"Evidence for a central component of post-injury pain hypersensitivity","volume":"306","author":"Woolf","year":"1983","journal-title":"Nature"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib62","first-page":"74","article-title":"Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier","volume":"6","author":"Beggs","year":"2010","journal-title":"Mol Pain"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib63","doi-asserted-by":"crossref","first-page":"H1241","DOI":"10.1152\/ajpheart.2001.280.3.H1241","article-title":"Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression","volume":"280","author":"Huber","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1460-9568.2002.01940.x","article-title":"Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain","volume":"15","author":"Ma","year":"2002","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/j.1532-2149.2013.00376.x","article-title":"Progesterone reduces the expression of spinal cyclooxygenase-2 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain","volume":"18","author":"Coronel","year":"2014","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcb.22520","article-title":"Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells","volume":"110","author":"Lu","year":"2010","journal-title":"J Cell Biochem"},{"issue":"24","key":"10.1007\/s13311-020-00912-8_bib67","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/MCB.23.24.9233-9244.2003","article-title":"Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1\u03b2 in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone H4 acetylation","volume":"23","author":"Nie","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000136751.04336.e9","article-title":"Bradykinin regulates cyclooxygenase-2 in rat renal thick ascending limb cells","volume":"44","author":"Rodriguez","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neulet.2006.03.026","article-title":"The long-term exposure of rat cultured dorsal root ganglion cells to bradykinin induced the release of prostaglandin E2 by the activation of cyclooxygenase-2","volume":"401","author":"Inoue","year":"2006","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pain.2007.08.017","article-title":"The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1\u03b2, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice","volume":"137","author":"Martucci","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.taap.2012.04.013","article-title":"Differential regulation of collagen secretion by kinin receptors in cardiac fibroblast and myofibroblast","volume":"261","author":"Catal\u00e1n","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"10.1007\/s13311-020-00912-8_bib72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1007\/s13311-020-00912-8_bib73","unstructured":"Sadoshima J, Novel AT1 receptor\u2013independent functions of losartan, 2002, Am Heart Assoc."},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib74","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1291\/hypres.28.593","article-title":"Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling","volume":"28","author":"Takai","year":"2005","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib75","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1471-4159.1982.tb10883.x","article-title":"Distribution of angiotensin-converting enzyme activity in specific areas of the rat brain stem","volume":"38","author":"Chevillard","year":"1982","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-020-00912-8_bib76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.nbd.2014.08.005","article-title":"Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke","volume":"71","author":"Chang","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-020-00912-8_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2008.09.099","article-title":"Expression and transport of angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat","volume":"1246","author":"Pavel","year":"2008","journal-title":"Brain Res"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib78","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1007\/s13311-020-00912-8_bib79","doi-asserted-by":"crossref","first-page":"e78695","DOI":"10.1371\/journal.pone.0078695","article-title":"NF-\u03baB and CREB are required for angiotensin II type 1 receptor upregulation in neurons","volume":"8","author":"Haack","year":"2013","journal-title":"Plos One"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib80","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.3892\/mmr.2017.7110","article-title":"Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system","volume":"16","author":"Yan","year":"2017","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cei.12467","article-title":"Angiotensin II in inflammation, immunity and rheumatoid arthritis","volume":"179","author":"Chang","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1007\/s13311-020-00912-8_bib82","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.112.199646","article-title":"Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats","volume":"60","author":"McCarthy","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib83","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","article-title":"Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke","volume":"40","author":"McCarthy","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1007\/s13311-020-00912-8_bib84","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pme.12063","article-title":"Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats","volume":"14","author":"Smith","year":"2013","journal-title":"Pain Medicine"},{"issue":"4","key":"10.1007\/s13311-020-00912-8_bib85","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0196-9781(92)90187-8","article-title":"Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing","volume":"13","author":"Viswanathan","year":"1992","journal-title":"Peptides"},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib86","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1210\/en.2008-0061","article-title":"Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system","volume":"149","author":"Chakrabarty","year":"2008","journal-title":"Endocrinology"},{"issue":"12","key":"10.1007\/s13311-020-00912-8_bib87","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1167\/iovs.06-0478","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation","volume":"47","author":"Kurihara","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1007\/s13311-020-00912-8_bib88","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1007\/s12035-015-9584-5","article-title":"Angiotensin receptor blockade modulates NF\u03baB and STAT3 signaling and inhibits glial activation and neuroinflammation better than angiotensin-converting enzyme inhibition","volume":"53","author":"Bhat","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1007\/s13311-020-00912-8_bib89","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/1570159X16666180510151241","article-title":"Experimental drugs for neuropathic pain","volume":"16","author":"Salat","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib90","first-page":"38","article-title":"Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT 2 R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies","volume":"11","author":"Anand","year":"2015","journal-title":"Mol Pain"},{"key":"10.1007\/s13311-020-00912-8_bib91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/JPR.S128520","article-title":"EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain","volume":"10","author":"Hesselink","year":"2017","journal-title":"J Pain Res"},{"issue":"1","key":"10.1007\/s13311-020-00912-8_bib92","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41598-020-61006-1","article-title":"Pregabalin inhibits in vivo and in vitro cytokine secretion and attenuates spleen inflammation in lipopolysaccharide\/concanavalin A -induced murine models of inflammation","volume":"10","author":"Abu-Rish","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1007\/s13311-020-00912-8_bib93","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.STR.0000129788.26346.18","article-title":"Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats","volume":"35","author":"Ando","year":"2004","journal-title":"Stroke"},{"issue":"2-3","key":"10.1007\/s13311-020-00912-8_bib94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/rej.2009.0944","article-title":"Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease","volume":"13","author":"Danielyan","year":"2010","journal-title":"Rejuvenation Res"},{"issue":"13","key":"10.1007\/s13311-020-00912-8_bib95","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","article-title":"Candesartan, an angiotensin II at 1-receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice","volume":"37","author":"Villapol","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-020-00912-8_bib96","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2013.07.016","article-title":"Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA","volume":"76","author":"Dominguez-Meijide","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1007\/s13311-020-00912-8_bib97","first-page":"289","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am J H"},{"issue":"2","key":"10.1007\/s13311-020-00912-8_bib98","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","article-title":"ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"55","author":"Coppey","year":"2006","journal-title":"Diabetes"},{"key":"10.1007\/s13311-020-00912-8_bib99","doi-asserted-by":"crossref","unstructured":"Malik RA, Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?, 2000 Taylor & Francis","DOI":"10.3109\/07853890008995903"}],"updated-by":[{"DOI":"10.1007\/s13311-023-01449-2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"record-id":"47960"},{"DOI":"10.1007\/s13311-023-01449-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00912-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:02:55Z","timestamp":1761807775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923013223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1878747923013223"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00912-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00912-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}